CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 10,046,344	$ 22,672,138
Prepaid expenses	598,377	762,063
Supplies used for R&D and manufacturing	1,893,683	2,001,715
Deposits	35,622	0
Total current assets	12,574,026	25,435,916
Finance lease right of use assets	10,034,892	10,937,797
Operating lease right of use assets	1,793,399	1,884,464
Property and equipment, net	11,179,697	11,889,029
Patent costs, net	192,231	212,201
Deposits	2,319,101	0
Supplies used for R&D and manufacturing	101,897	164,299
Total assets	38,195,243	50,523,706
Current liabilities:
Accounts payable	1,888,911	1,618,290
Accrued expenses	1,064,007	842,492
Due to employees	509,286	471,488
Lease liabilities, current portion	1,849,749	1,731,481
Total current liabilities	5,311,953	4,663,751
Finance lease obligations, net of current portion	10,855,289	11,721,368
Operating lease obligations, net of current portion	1,755,401	1,850,380
Other liabilities	125,000	125,000
Total liabilities	18,047,643	18,360,499
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; 200,000 shares authorized; 0 shares issued and outstanding	0	0
Common stock, $.01 par value; 600,000,000 shares authorized; 43,787,825 and 43,448,317 shares issued and outstanding at March 31, 2023 and September 30, 2022, respectively	437,878	434,484
Additional paid-in capital	490,803,133	486,625,816
Accumulated deficit	(471,093,411)	(454,897,093)
Total stockholders' equity	20,147,600	32,163,207
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 38,195,243	$ 50,523,706